Sivers delivered another quarter of solid underlying progress, highlighted by strong FX-neutral growth and increasing customer traction. While reported figures came in slightly below our expectations, the company’s strategic and financial transformation over the past year continues to strengthen our conviction in the long-term case. We nudge our Base Case up to SEK5.8 (5.6), reflecting solid execution and an improving quality profile.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/